The results include the notice of the Minister of Health, effective 1st of January 2022.
We track the Minister of Health’s reimbursement decisions and AHTAPol’s statements and recommendations for drugs with no reimbursed equivalents. With our PREDECIZER approach, we analyzed the decision-making practice of the 12-month period from the latest notice compared to the 12-month period of the preceding notice.
Full presentation:
Contact: development@inar.pl
Analysis of the Reimbursement Decision-Making Practice in Poland (January 2022)
